MedTrace Logo

Nanocrystalline Hydroxyapatite Bone Substitute for Treating Periodontal Intrabony Defects

NCT04643288 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2020-11-27

No results posted yet for this study

Summary

The present clinical trial included 20 patients (11 females and 9 males, aged 36 to 56 years) suffering from moderate or advanced chronic periodontitis. Subjects were recruited from the outpatient clinic, Department of Oral Medicine and Periodontology, Faculty of Dentistry, Cairo University. This clinical trial was meant to assess clinically and radiographically the possible predictable results regarding the use of nanocrystalline hydroxyapatite bone graft substitute together with open flap debridement versus open flap debridement alone in the treatment of periodontal intrabony defects.

Conditions

  • Chronic Periodontitis

Interventions

PROCEDURE

open flap debridement

open flap debridement for managing two and three walls intrabony periodontal defects

PROCEDURE

n-HA bone graft

Nanocrystalline Hydroxyapatite bone graft substitute for managing two and three walls intrabony periodontal defects

Sponsors & Collaborators

  • Weam Ahmed Elbattawy

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
56 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-01
Primary Completion
2019-11-25
Completion
2020-05-25

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04643288 on ClinicalTrials.gov